Dr. Goodman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9280 W Sunset Rd
Ste 100
Las Vegas, NV 89148Phone+1 702-952-1251Fax+1 702-952-1242
Summary
- Dr. Oscar Goodman is an oncologist in Las Vegas, NV and is affiliated with multiple hospitals in the area, including Southern Hills Hospital and Medical Center, St. Rose Dominican Hospitals - San Martin Campus, and Spring Valley Hospital Medical Center. He received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 18 years. He specializes in genitourinary oncology.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2002 - 2005- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2001
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1999
Certifications & Licensure
NV State Medical License 2007 - 2025
NY State Medical License 2001 - 2008- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2011 Dec 01
- A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Publications & Presentations
PubMed
- 36 citationsTelaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial.Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, Marc Matrana, Ivor Percent
Clinical Cancer Research. 2022-08-02 - 16 citationsPhase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer.Christopher J Sweeney, Ivor J Percent, Sunil Babu, Jennifer L Cultrera, Bryan A Mehlhaff
Clinical Cancer Research. 2022-06-01 - 56 citationsApalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a random...Fred Saad, Eleni Efstathiou, Gerhardt Attard, Thomas W. Flaig, Fabio Franke
The Lancet. Oncology. 2021-11-01
Press Mentions
Medical Education EvolutionThe Making of the Kirk Kerkorian School of MedicineDecember 2nd, 2022- The Making of a Med SchoolApril 27th, 2021
- Providing Critical Support from the BeginningMarch 26th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
